These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. The designer leptin antagonist peptide Allo-aca compensates for short serum half-life with very tight binding to the receptor. Otvos L; Vetter SW; Koladia M; Knappe D; Schmidt R; Ostorhazi E; Kovalszky I; Bionda N; Cudic P; Surmacz E; Wade JD; Hoffmann R Amino Acids; 2014 Apr; 46(4):873-82. PubMed ID: 24366600 [TBL] [Abstract][Full Text] [Related]
18. IGFBP‑rP1‑silencing promotes hypoxia‑induced angiogenic potential of choroidal endothelial cells via the RAF/MEK/ERK signaling pathway. Zhu S; Wang H; Zhang Z; Ma M; Zheng Z; Xu X; Sun T Mol Med Rep; 2020 Dec; 22(6):4837-4847. PubMed ID: 33173998 [TBL] [Abstract][Full Text] [Related]
19. The molecular mechanism of action of superactive human leptin antagonist (SHLA) and quadruple leptin mutein Lan-2 on human ovarian epithelial cell lines. Fiedor E; Gregoraszczuk EŁ Cancer Chemother Pharmacol; 2016 Sep; 78(3):611-22. PubMed ID: 27480179 [TBL] [Abstract][Full Text] [Related]
20. Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells. Cascio S; Ferla R; D'Andrea A; Gerbino A; Bazan V; Surmacz E; Russo A J Cell Physiol; 2009 Oct; 221(1):189-94. PubMed ID: 19492417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]